Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. - sprookjes - yvandenbroek - TriplyDB

Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis.

Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis.

http://www.wikidata.org/entity/Q35103511

about

Potential function of miRNAs in herpetic stromal keratitis Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization Clinical correlates of common corneal neovascular diseases: a literature review Topical Use of Angiopoietin-like Protein 2 RNAi-loaded Lipid Nanoparticles Suppresses Corneal Neovascularization Gene delivery to cornea.Short interfering RNA (siRNA) as a novel therapeutic.Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy Advances in Systemic siRNA Delivery VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Targeted suppression of HO-2 gene expression impairs the innate anti-inflammatory and repair responses of the cornea to injury.Herpes simplex virus keratitis: histopathology and corneal allograft outcomes Efficient and targeted delivery of siRNA in vivo.Herpes keratitis.Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma.Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon.Corneal neovascularization: an anti-VEGF therapy review.Corneal lymphangiogenesis in herpetic stromal keratitis Nanomedicine in GI PEI-g-PEG-RGD/small interference RNA polyplex-mediated silencing of vascular endothelial growth factor receptor and its potential as an anti-angiogenic tumor therapeutic strategy Activation of endothelial roundabout receptor 4 reduces the severity of virus-induced keratitis.An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology.Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells Nanotechnology for energy-based cancer therapies Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)Harnessing RNAi nanomedicine for precision therapy IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection Robo 4 Counteracts Angiogenesis in Herpetic Stromal Keratitis Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)Nanoparticle-mediated delivery of shRNA.VEGF-a plasmids regresses corneal neovascularization Silencing of Rac1 expression via RNA interference inhibits retinal neovascularization in rats.Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis siRNA-mediated inhibition of angiogenesis.Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus.Suppression of transcription factor early growth response 1 reduces herpes simplex virus 1-induced corneal disease in mice Inhibition of VEGF expression and corneal neovascularization by siRNA targeting cytochrome P450 4B1.Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders.The silent treatment: siRNAs as small molecule drugs.

P2860

Q26823201-50771B21-9941-4A50-8559-8D6414C4C262 Q26859021-1C3F6E68-BFFD-49B9-BD27-BCC629B11EFB Q27023951-4E22E188-93BF-49BD-B5F8-DEF93D5886C4 Q28257676-C0198951-F6D0-4927-BAB6-2F8D1BA7BCA8 Q28831101-EDB5644D-8976-4C9C-A7B2-B5753AC6DC93 Q30476991-273385F1-8F40-4B27-9244-AB1AD48BA50D Q33243420-51C1537D-86E1-4202-A66C-8B6FED7ECB24 Q33379554-1F7D2F99-D965-4776-B925-960E0C42EEEC Q33613316-E71FD591-0E1A-4C1B-946B-F04581C3949D Q33615188-9DF8057C-6D21-4A88-8976-DF66390D5C28 Q33692555-139B7ED4-54B6-4AB7-A7CC-2C93144985C0 Q33892448-9160CF76-68A8-41F1-82A8-F107B139D03F Q33904084-90E43899-E584-48AE-B723-50747FC1371A Q34149828-BC70C152-4635-478B-9059-E1984C7D1A47 Q34297293-3E27BC54-28B3-434E-897B-0184927070E8 Q34334362-1A1A88A7-72D1-472A-BAE2-91514E459163 Q34354205-9AB63EFF-9B54-4759-91F3-08C1397F6C06 Q34641522-4D116C3E-C740-4D88-A5E1-7329AA714ECF Q34674612-2A13025B-F484-4BEA-AC91-E5237130615E Q34719056-1CE7170E-8C10-42A1-A1E3-5191C9BE029C Q34805909-B763CF59-F277-43DD-95FB-92B609289051 Q35037318-21D356B5-1964-4376-BBE6-3B4EA418DE97 Q35076957-1B7BC353-1FAF-4A05-A849-E44C999BC3A7 Q35159211-AFF4815C-DDF5-4F22-8060-3CC28297DFAD Q35264028-B1A4CDCF-4791-439B-A3E0-0EAB1DECD150 Q35566669-2A88F08F-A05D-49D9-9288-8685E2C4E40C Q35662667-EF2A4CDC-1B20-4047-B786-38A3D3A39695 Q35673875-F5C6E145-7D7C-41BD-95CA-5BF4401EBF0F Q35850771-D0BBE365-ECE6-4B6B-BC78-119E661A0FDC Q35882555-1B52963E-35EA-4956-AA1F-665506BA0CA3 Q35956190-99E93925-3D2C-4F6C-8D40-0779E153EEF4 Q36009031-0D2A5E8F-6862-4163-B76D-135FF48BFF71 Q36015790-2C3AD5E7-1025-4BBA-A8CD-BAF6329FF372 Q36099335-A75DB33B-2479-45EA-B72D-386E139AEF88 Q36099464-CF805009-26C6-4483-BDD3-A98EAF35623B Q36131519-9E14F44F-A460-404D-B30E-FC026B4CF357 Q36171987-46CD88FB-CFAF-41F3-814C-A0BDD733F453 Q36248876-7F27DF22-0BBE-4BDE-932D-520A15FD4372 Q36272954-C62A7CD3-F0F0-45BA-B959-667D85A43FAB Q36362370-9D3612AA-3C55-413B-A64E-CD18685BBD0C

P2860

Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis.

http://www.wikidata.org/entity/Q35103511

description

2004 nî lūn-bûn

@nan

2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Inhibition of ocular angiogene ...... or herpetic stromal keratitis.

@ast

Inhibition of ocular angiogene ...... or herpetic stromal keratitis.

@en

type

label

Inhibition of ocular angiogene ...... or herpetic stromal keratitis.

@ast

Inhibition of ocular angiogene ...... or herpetic stromal keratitis.

@en

prefLabel

Inhibition of ocular angiogene ...... or herpetic stromal keratitis.

@ast

Inhibition of ocular angiogene ...... or herpetic stromal keratitis.

@en

P1433

Q35103511-14CDC978-F335-4E45-9309-E19566349A0A

P1476

Q35103511-D3101E91-C48C-43D4-AA2C-2F7B24410C12

P2093

Q35103511-03FD57A2-C250-4689-A140-C6AF16DFF368

Q35103511-240B0D9E-BD7E-40D5-B611-3AA1D2BBB173

Q35103511-2566E9A8-2CFC-4400-9D97-C605BEEBF83D

Q35103511-2AB80798-8199-4D6A-88B6-726CA1146279

Q35103511-3EB4E050-795B-4AC6-8459-CA21E887FCDC

Q35103511-7C9E6A5E-7BB5-4E0C-AC02-DF9491D69AD4

Q35103511-9946B16F-9093-4334-88C0-E5B31F7A7364

Q35103511-AA6DCA31-E7AA-4994-8498-01973C53164B

Q35103511-B31823A1-2374-4577-8C11-94E9C46CB2A1

Q35103511-BEBDDF91-6BE1-4552-B674-9D4DCD98FE02

P2860

Q35103511-020B9D35-4D92-4825-892D-88F5AA32ED52

Q35103511-38E456A0-7D9F-4364-BB47-C63D0182C49E

Q35103511-3CE645B3-EAB7-41DC-A290-A4CB2F1D1B7C

Q35103511-600FB05B-8DF9-4427-B4AB-01C1E481EC37

Q35103511-602364D6-45C8-4E60-8C00-B57B9011FD1C

Q35103511-6F150260-5115-4FB0-93F4-8361A76526C9

Q35103511-74B0DFAF-E05E-48C7-8EF2-BE5A2DFCFBBE

Q35103511-78AC1C76-16BB-4749-941F-2EBCBA433ACA

Q35103511-90A6D4AC-2C0D-4D74-8353-ED887B19C84C

Q35103511-914F49A8-6FEC-4D97-B1D6-EB0270DD3D96

P304

Q35103511-BC6EE0E1-6F63-45FF-A469-03EB50E35CB8

P31

Q35103511-EF0C0E44-3A68-4ABB-89A2-0D0E808B0886

P356

Q35103511-D178DC98-7497-475E-A320-2EFC45099853

P407

Q35103511-A8755D8D-B782-495D-B8D4-B6739EE0D4BF

P433

Q35103511-242C0A55-A044-4B8A-AC26-9BA4A35AB69E

P478

Q35103511-E89769DA-34E1-416C-A944-5C7C73A41B63

P577

Q35103511-E6A45725-5E9D-4647-8F0A-E780E640527E

P698

Q35103511-556B8ECD-7EA0-466A-99A1-06EBFEE0179E

P921

Q35103511-715DE754-85A7-4321-AED3-0DA611D69ED8

P932

Q35103511-E7552FD1-E4E2-4ADB-BD3D-748699AEFB2F

P356

S0002-9440(10)63267-1

P1433

The American Journal of Pathology

P1476

Inhibition of ocular angiogene ...... or herpetic stromal keratitis.

@en

P2093

Aslam M Ansari

http://www.w3.org/2001/XMLSchema#string

Barry T Rouse

http://www.w3.org/2001/XMLSchema#string

Bumseok Kim

http://www.w3.org/2001/XMLSchema#string

Frank Y Xie

http://www.w3.org/2001/XMLSchema#string

Jun Xu

http://www.w3.org/2001/XMLSchema#string

Martin C Woodle

http://www.w3.org/2001/XMLSchema#string

Partha S Biswas

http://www.w3.org/2001/XMLSchema#string

Patrick Lu

http://www.w3.org/2001/XMLSchema#string

Puthupparampil V Scaria

http://www.w3.org/2001/XMLSchema#string

Qingquan Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

New perspectives in cell adhesion: RGD and integrins

Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders

Poly(ethylenimine) and its role in gene delivery.

Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis.

RNA interference and small interfering RNAs.

DNA containing CpG motifs induces angiogenesis.

Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells.

P304

2177-2185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)63267-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15579459

http://www.w3.org/2001/XMLSchema#string

P921

P932

1618707

http://www.w3.org/2001/XMLSchema#string